Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Replimune to Present at Three Upcoming Investor Conferences | ||
By: GlobeNewswire - 05 Mar 2024 | Back to overview list |
|
WOBURN, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced that members from the Replimune management team will present and host investor meetings at the following three conferences: Leerink Partners 2024 Global Biopharma Conference Jefferies Biotech on the Bay Miami Summit Barclays 26th Annual Global Healthcare Conference Live webcasts of the Leerink and Barclays fireside chats will be available in the Investors section of Replimune’s website at www.replimune.com. A replay will be available for 30 days following the conference. About Replimune Investor Inquiries Media Inquiries |
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |